Ipek Erdogan-Trinkaus
Chief Commercial Officer, Eton Pharmaceuticals, Inc.
Companies
- Eton Pharmaceuticals, Inc.Chief Commercial Officer Dec 9, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Eton Pharmaceuticals, Inc. ETON2,403 shares2$119.2K at $49.62Dec 12, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 12, 2025Shares withheld for tax 85 shares at $16.90 of Eton Pharmaceuticals, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2